DEA's new telehealth rules are bad news for trans people on testosterone

By them
| March 28, 2023

The DEA is considering a rule that would end telemedicine prescriptions for controlled substances unless the patient has had an in-person appointment.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...